A hospital's infection control committee is reviewing occupational exposure protocols. As part of a case-based training module for incoming residents, several distinct Hepatitis B serological profiles are presented to assess proficiency in post-exposure evaluation. Match each specific clinical interpretation with its corresponding Hepatitis B serological profile.
- Acute Hepatitis B, high infectivity phaseHBsAg (+), Anti-HBs (-), Anti-HBc IgM (+), HBeAg (+)
- Chronic Hepatitis B, low infectivity carrier stateHBsAg (+), Anti-HBs (-), Anti-HBc IgG (+), HBeAg (-), Anti-HBe (+)
- Immunity due to resolved natural infectionHBsAg (-), Anti-HBs (+), Anti-HBc IgG (+), HBeAg (-), Anti-HBe (+)
- Immunity due to vaccination series completionHBsAg (-), Anti-HBs (+), Anti-HBc (-), HBeAg (-), Anti-HBe (-)
- Acute Hepatitis B, window periodHBsAg (-), Anti-HBs (-), Anti-HBc IgM (+), HBeAg (-), Anti-HBe (-)
Answer
Acute Hepatitis B (high infectivity) matches with HBsAg(+)/Anti-HBc IgM(+)/HBeAg(+). Chronic Hepatitis B (low infectivity) matches with HBsAg(+)/Anti-HBc IgG(+)/Anti-HBe(+). Resolved natural infection matches with HBsAg(-)/Anti-HBs(+)/Anti-HBc IgG(+). Vaccination immunity matches with isolated Anti-HBs(+). The window period matches with isolated Anti-HBc IgM(+).
Each specific Hepatitis B serology profile corresponds to a distinct phase of the host-virus interaction. Surface antigen (HBsAg) drives acute and chronic states, while surface antibody (Anti-HBs) provides immunity. The presence or absence of core antibodies (Anti-HBc) perfectly distinguishes natural exposure from vaccination, and the envelope markers (HBeAg/Anti-HBe) act as a gauge for viral replication.
Step-by-Step Solution
Key Concept
Interpretation of Hepatitis B serological panels to distinguish between acute disease, chronic carriage, resolved infection, and vaccine-induced immunity.